Mar 30 2023
A sublingual spray that contains both CBD and THC “could be a new therapeutic agent for lipid and glycemic control in diabetic patients”, according to a double-blind, placebo-controlled clinical trial published by the Iranian Journal of Pharmaceutical Research, and epublished by the U.S. National Library of Medicine. Conducted by researchers at Shahid Beheshti University of …
Mar 25 2023
The cannabis compound cannabidiol (CBD) “acts as neuroprotector in dopaminergic neurons, reducing neurotoxicity and α-syn accumulation highlighting its potential in the treatment of PD”, according to a new study. The study is being published in the recent issue of the journal Neurochemical Research, and it was epublished online ahead of print by the National Library …
Mar 23 2023
Administering marijuana-derived CBD significantly reduces opioid cravings in animals, according to a new study published in the journal Addiction Neuroscience. For the study researchers from Washington State University and Legacy Research Institute in Portland examined the efficacy and safety profile of vaporized CBD in female rates. They found that rats provided with CBD were less likely to …
Mar 22 2023
Cannabidiol (CBD) was efficient in preventing chemotherapy-induced neuropathic pain in a new study published by the Journal of Pharmacy and Pharmacology. The study “aimed to investigate the effect of cannabidiol (CBD) on type 4 Toll-like receptors (TLR4), glial cells and pro-inflammatory cytokines during the neuropathic pain induced by the chemotherapy agent paclitaxel (PTX), as well …
Mar 21 2023
A cell membrane bionic delivery system for CBD assisted with ultrasound “had good therapeutic effect against PTSD mice”, and may help to “alleviate the symptoms of PTSD.” This is according to a new study published by the International Journal of Pharmaceutics. The study was conducted by researchers at the Shandong University of Traditional Chinese Medicine, …
Mar 19 2023
A new study published in the journal Drug and Alcohol Review details just how much Canada’s legal cannabis market has grown since being legalized in 2018. Titled Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation, the study was conducted by researchers at the Ottawa Hospital Research Institute, the …
Mar 16 2023
In a new study published by the Journal of Psychoactive Drugs the vast majority of U.S. veterans “reported positive outcomes for pain, sleep, and emotional problems because of cannabis use in two survey periods.” “Medical cannabis use among U.S. Veterans has continued to rise”, notes the abstract of the study, which was conducted by researchers …
Mar 14 2023
The cannabis compound cannabigerol (CBG) may be useful in combatting pain, according to new research published in the recent issue of the journal Biomedicine & Pharmacotherapy As noted by the study’s abstract, the antinociceptive activity of tetrahydrocannabinol (THC) or cannabidiol (CBD) has been widely studied. However, “the antinociceptive effects of other cannabis components, such as cannabichromene …
Mar 13 2023
A study published by the peer-reviewed journal Addiction has found that there “were no statistically significant changes in rates of emergency department visits and hospitalizations for motor vehicle or pedestrian/cyclist injury” following Canada legalizing marijuana. Titled The effect of recreational cannabis legalization on rates of traffic injury in Canada, the study was published by researchers …
Mar 13 2023
A single dose of cannabidiol (CBD) “positively influences measures of stress in dogs during separation and car travel”, according to a new study published by the journal Frontiers in Veterinary Science. Conducted by researchers at the Waltham Petcare Science Institute at Waltham on the Wolds, the study is titled A single dose of cannabidiol (CBD) …
